LT - ENANTIOMERS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE (ANAVEX2-73) AND USE THEREOF IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISORDERS MODULATED BY THE SIGMA 1 RECEPTOR
EN - ENANTIOMERS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE (ANAVEX2-73) AND USE THEREOF IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISORDERS MODULATED BY THE SIGMA 1 RECEPTOR
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/341 |
(2006.01) |
|
|
C07D 231/22 |
(2013.01) |
|
|
A61P 25/28 |
(2006.01) |
|
|
G01N 33/5005 |
(2013.01) |
|
|
C07D 307/14 |
(2006.01) |
|
|
A61K 31/341 |
(2013.01) |
|
|
G01N 33/567 |
(2006.01) |
|
|
A61P 25/28 |
(2018.01) |
European patent
| (11) |
Number of the document |
3324956 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
16827322.5 |
|
Date of filing the European patent application |
2016-07-19 |
| (97) |
Date of publication of the European application |
2018-05-30 |
| (45) |
Date of publication and mention of the grant of the patent |
2024-11-20
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/IB2016/001158 |
|
Date |
2016-07-19 |
PCT application publication
| (87) |
Number |
WO 2017/013496 |
|
Date |
2017-01-26 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
201562195417 P |
2015-07-22
|
US |
Inventors
| (72) |
NELIAT, Gervais , US
|
Grantee
| (73) |
Anavex Life Sciences Corp. ,
51 West 52nd Street 7th Floor, New York, NY 10019,
US
|
Title
| (54) |
ENANTIOMERS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE (ANAVEX2-73) AND USE THEREOF IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISORDERS MODULATED BY THE SIGMA 1 RECEPTOR |
| |
ENANTIOMERS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE (ANAVEX2-73) AND USE THEREOF IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISORDERS MODULATED BY THE SIGMA 1 RECEPTOR |
